Join BJS Academy
BJS Academy>Randomized clinical ...>Presurgical oral tam...
Normal View Dyslexic View

Presurgical oral tamoxifen vs transdermal 4-hydroxytamoxifen in women with ductal carcinoma in situ. A randomized clinical trial.

13 February 2024
Randomized clinical trials Breast
Khan SA, Mi X, Blanco Jr LZ, Akasha AM, Pilewskie M, Degnim AC et al.

JAMA Surg 2023;158: 1265-1273.

In this trial that included 75 evaluable patients, use of tamoxifen gel on the breast skin did not have similar biochemical changes to use of oral tamoxifen preoperatively. In addition the DCIS score decreased more with oral tamoxifen.

Comment: This formulation is not an acceptable alternative to Tamoxifen tablets.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct040
Randomized clinical trials
Randomized clinical trials
Breast
Presurgical oral tamoxifen vs transdermal 4-hydroxytamoxifen in women with ductal carcinoma in situ. A randomized clinical trial.
Khan SA, Mi X, Blanco Jr LZ, Akasha AM, Pilewskie M, Degnim AC et al.
13022024
JAMA Surg 2023;158: 1265-1273.
In this trial that included 75 evaluable patients, use of tamoxifen gel on the breast skin did not have similar biochemical changes to use of oral tamoxifen preoperatively. In addition the DCIS score decreased more with oral tamoxifen.
Comment: This formulation is not an acceptable alternative to Tamoxifen tablets.
Published on: 13 February 2024
Article ID: rct040

Related articles

Aspirin vs placebo as adjuvant therapy for breast cancer. The Alliance A011502 randomized trial.

Chen WY, Ballman KV, Partridge AH, Hahn OM, Briccetti FM et al.

16 August 2024

21-Gene assay to inform chemotherapy benefit in node-positive breast cancer.

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF et al.
N Engl J Med 2021; 385: 2336-2347

1 January 2022

Event-free survival with pembrolizumab in early triple-negative breast cancer.

Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kummel S et al, for the KEYNOTE-522 Investigators.
N Engl J Med 2022; 386: 556-567.

1 March 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!